Form 4 for MET MetLife
Accepted 2024-12-17 00:00:00 ET · period of report 2024-12-13 · accession 0001099219-24-000270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-17 | 2024-12-13 | MET | DEBEL MARLENE | EVP, CRO | M - OptEx | $39.26 | +22.8K | 131.3K | +21% | +$895.4K |
| D | 2024-12-17 | 2024-12-13 | MET | DEBEL MARLENE | EVP, CRO | S - Sale+OE | $82.88 | -22.8K | 108.5K | -17% | -$1.89M |
| DM | 2024-12-17 | 2024-12-13 | MET | DEBEL MARLENE | EVP, CRO | M - OptEx | $0.00 | -22.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-13 | M | A | 13,107 | $34.33 | 121,614 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-13 | M | A | 9,703 | $45.91 | 131,317 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-13 | S | D | 22,810 | $82.88 | 108,507 | D | — | — | (F1) The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. |
| 4 | Derivative | Employee Stock Options (right to buy) | 2024-12-13 | M | D | 13,107 | $0.00 | 0 | D | $34.33 · — to 2026-02-22 | 13,107 Common Stock | (F2) The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019. |
| 5 | Derivative | Employee Stock Options (right to buy) | 2024-12-13 | M | D | 9,703 | $0.00 | 0 | D | $45.91 · — to 2025-02-23 | 9,703 Common Stock | (F3) The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018. |